Search results for "Hypertensive"

showing 10 items of 250 documents

Matrix Metalloproteases in Arterial Hypertension and their Trend after Antihypertensive Treatment

2017

<b><i>Background/Aims</i></b><b><i>:</i></b> Arterial hypertension is characterized by vascular remodelling, atherosclerosis and cardiovascular complications. Matrix metalloproteases (MPPs) are endopeptidases produced by all the cells present in the vascular wall and are involved in the regulation of the extracellular matrix protein turnover. MMPs contribute to blood vessel formation, remodelling, angiogenesis; whereas an altered expression or activity of MMPs or their tissue inhibitors (TIMPs) results correlated with the development and progression of cardiovascular complications. <b><i>Methods:</i></b> We examined the…

Arterial hypertensionVascular remodelling0301 basic medicinelcsh:Diseases of the circulatory (Cardiovascular) systemmedicine.medical_specialtyAngiogenesisMatrix metalloproteasesMatrix metalloproteaseHemodynamics030204 cardiovascular system & hematologyPharmacologyMatrix metalloproteinaselcsh:RC870-923Vascular remodelling in the embryoExtracellular matrix03 medical and health scienceschemistry.chemical_compound0302 clinical medicineFibrosisInternal medicinelcsh:DermatologymedicineHumansAntihypertensive AgentsAldosteronebusiness.industryTissue Inhibitor of MetalloproteinasesGeneral Medicinelcsh:RL1-803lcsh:Diseases of the genitourinary system. Urologymedicine.diseaseMatrix Metalloproteinases030104 developmental biologymedicine.anatomical_structurechemistrylcsh:RC666-701Cardiovascular DiseasesNephrologyHypertensionCardiologyArterial hypertension; Matrix metalloproteases; Vascular remodelling; Cardiology and Cardiovascular Medicine; NephrologyCardiology and Cardiovascular MedicinebusinessBlood vesselKidney and Blood Pressure Research
researchProduct

Metabolic syndrome in hypertensive patients: An unholy alliance

2014

For many years, it has been recognized that hypertension tends to cluster with various anthropometric and metabolic abnormalities including abdominal obesity, elevated triglycerides, reduced high-density lipoprotein cholesterol, glucose intolerance, insulin resistance and hyperuricemia. This constellation of various conditions has been transformed from a pathophysiological concept to a clinical entity, which has been defined metabolic syndrome (MetS). The consequences of the MetS have been difficult to assess without commonly accepted criteria to diagnose it. For this reason, on 2009 the International Diabetes Federation, the American Heart Association and other scientific organizations pro…

Arterial hypertensionmedicine.medical_specialtySettore MED/09 - Medicina InternaEnd organ damageType 2 diabetesOverweightLeft ventricular hypertrophyInsulin resistanceHypertensive retinopathyInternal medicineMedicineTopic HighlightAbdominal obesityTarget organ damageSettore MED/14 - Nefrologiabusiness.industryCardiovascular riskmedicine.diseaseMetabolic syndromeSettore MED/11 - Malattie Dell'Apparato CardiovascolareEndocrinologyCardiologyMetabolic syndromemedicine.symptomCardiology and Cardiovascular Medicinebusiness
researchProduct

Is diet partly responsible for differences in COVID-19 death rates between and within countries?

2020

Abstract Reported COVID-19 deaths in Germany are relatively low as compared to many European countries. Among the several explanations proposed, an early and large testing of the population was put forward. Most current debates on COVID-19 focus on the differences among countries, but little attention has been given to regional differences and diet. The low-death rate European countries (e.g. Austria, Baltic States, Czech Republic, Finland, Norway, Poland, Slovakia) have used different quarantine and/or confinement times and methods and none have performed as many early tests as Germany. Among other factors that may be significant are the dietary habits. It seems that some foods largely use…

BLOOD-PRESSUREReviewAngiotensin-converting enzyme; Antioxidant; Coronavirus; Diet; Foodlaw.inventionDietary interventions0302 clinical medicine[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases10183 Swiss Institute of Allergy and Asthma ResearchlawMedicine and Health SciencesImmunology and AllergyMedicine030212 general & internal medicine[SDV.MHEP.ME] Life Sciences [q-bio]/Human health and pathology/Emerging diseases[SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseaseseducation.field_of_studyMortality rate3. Good health[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases2723 Immunology and AllergyAntioxidantAngiotensin-converting enzymeAngiotensin-converting enzyme Antioxidant Coronavirus Diet FoodPulmonary and Respiratory Medicine2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)CoronaviruImmunologyPopulation610 Medicine & healthCOVID-19 ; Food ; Angiotensin-converting enzyme ; Diet ; Antioxidant ; CoronavirusSettore MED/10 - Malattie Dell'Apparato Respiratorio03 medical and health sciencesEnvironmental healthCOVID-19 ; population ; angiotensin-converting enzymeQuarantineeducation2403 ImmunologyANTIHYPERTENSIVE PEPTIDESbusiness.industryRC581-607GENEPOLYMORPHISMDietCoronavirus[SDV.AEN] Life Sciences [q-bio]/Food and Nutrition030228 respiratory system2740 Pulmonary and Respiratory MedicineFoodImmunologic diseases. Allergybusiness[SDV.AEN]Life Sciences [q-bio]/Food and NutritionRegional differencesCoronavirus Infections
researchProduct

Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide.

2020

Obesity has reached epidemic proportions in the United States and in much of the westernized world, contributing to considerable morbidity. Several of these obesity-related morbidities are associated with greater risk for death with coronavirus disease 2019 (COVID-19). Severe acute respiratory syndrome coronavirus 2 penetrates human cells through direct binding with angiotensin-converting enzyme 2 receptors on the cell surface. Angiotensin-converting enzyme 2 expression in adipose tissue is higher than that in lung tissue, which means that adipose tissue may be vulnerable to COVID-19 infection. Obese patients also have worse outcomes with COVID-19 infection, including respiratory failure, n…

BMI body mass indexmedicine.medical_treatmentAdipose tissue030204 cardiovascular system & hematologyCHD coronary heart diseaseHF heart failureUS United States0302 clinical medicineRAAS renin-angiotensin-aldosterone systemPandemicMedicine030212 general & internal medicineCDC Centers for Disease Control and PreventionCOVID-19 coronavirus disease 2019TNF tumor necrosis factorHFpEF HF with preserved ejection fractionCV cardiovascularGeneral MedicinePrognosisICU intensive care unitPA physical activityMetS metabolic syndromePAH pulmonary arterial hypertensionCoronavirus Infectionsmedicine.medical_specialtyAF atrial fibrillationACE angiotensin-converting enzymePneumonia ViralCVD cardiovascular diseaseSARS-CoV-2 severe acute respiratory syndrome coronavirus 2ArticleSeverity03 medical and health sciencesBetacoronavirusInternal medicineIPF idiopathic pulmonary fibrosisHumansObesityMortalityHTN hypertension or hypertensivePandemicsMechanical ventilationAng II angiotensin IIbusiness.industrySARS-CoV-2CKD chronic kidney diseaseCOVID-19T2DM type 2 diabetes mellitusmedicine.diseaseAngiotensin IIObesityIL interleukinPneumoniaRespiratory failureMetabolic syndromebusinessSNS sympathetic nervousMayo Clinic proceedings
researchProduct

Hypertension treatment in patients with sleep apnea from the European Sleep Apnea Database (ESADA) cohort - towards precision medicine.

2022

We recruited 5,970 patients with hypertension with obstructive sleep apnea (OSA) on current antihypertensive treatment from the European Sleep Apnea Database (ESADA) cohort. The group was subdivided into those receiving monotherapy (n = 3,594) and those receiving dual combined therapy (n = 2,376). We studied how major OSA confounders like age, gender, and body mass index as well as the degree of sleep apnea modified office systolic and diastolic blood pressure. Beta-blockers alone or in combination with a diuretic were compared with other antihypertensive drug classes. Monotherapy with beta-blocker was associated with lower systolic blood pressure, particularly in non-obese middle-aged male…

Behavioral NeurosciencehypertensionCognitive Neurosciencediureticbeta-blockerobstructive sleep apnea.General MedicineSettore MED/10 - Malattie Dell'Apparato Respiratorioantihypertensive treatmentJournal of sleep researchREFERENCES
researchProduct

Liver oleic acid biogenesis is impaired during the prehypertensive period in the spontaneously hypertensive rat.

2003

In the present study, we have investigated the liver microsomal stearic acid delta9 desaturation, and the fatty acid composition of liver microsomal total lipids in 10- and 30-day-old spontaneously hypertensive rats (SHRs), compared to the normotensive Wistar Kyoto (WKY) control rats. So as to avoid any influence related to the diet, the composition of the milk being different in SHR and WKY strains, the pups were suckled by adoptive normotensive female Wistar. After weaning, the 30-day-old rats were fed a standard commercial diet and then killed. Our results show lower liver microsomal delta9 desaturase activities in the 10- and 30-day-old SHR versus the WKY of the same age. The fatty acid…

Blood GlucoseFatty Acid DesaturasesMalemedicine.medical_specialtyAgingClinical BiochemistryBiologyRats Inbred WKYchemistry.chemical_compoundSpontaneously hypertensive ratInternal medicineRats Inbred SHRmedicineWeaningAnimalsRats WistarBody WeightFatty AcidsLipid metabolismCell BiologyOrgan SizeRatsOleic acidEndocrinologyEicosanoidchemistryAnimals NewbornLiverHypertensionMicrosomeMicrosomes LiverStearic acidStearoyl-CoA DesaturaseHormoneOleic AcidProstaglandins, leukotrienes, and essential fatty acids
researchProduct

Losartan reduces microalbuminuria in hypertensive microalbuminuric type 2 diabetics.

2001

Background. The aim of the present study was to assess the antialbuminuric effect of losartan in a large number of hypertensive type 2 diabetics. Methods. This was a 6-month, open-label, prospective and multicentre study. A total of 422 patients with type 2 diabetes who were hypertensive [sitting systolic blood pressure (SBP) > 140 mmHg and/or diastolic blood pressure (DBP) ≥90 mmHg] and microalbuminuric [urinary albumin excretion (UAE) 30-300 mg/day] were eligible for the study. After a 2-week run-in period, patients were placed on losartan 50 mg once a day. If the BP did not reach the desired goal (<140/90 mmHg) after a 4-week period, the losartan dose was doubled. In the absence of contr…

Blood Glucosemedicine.medical_specialtySystoleUrologyRenal functionBlood PressureType 2 diabetesLosartanDiabetic nephropathyDiastoleDiabetes mellitusInternal medicinemedicineAlbuminuriaHumansAntihypertensive AgentsGlycated HemoglobinTransplantationbusiness.industryBody Weightmedicine.diseaseAngiotensin IIUric AcidLosartanEndocrinologyBlood pressureHydrochlorothiazideDiabetes Mellitus Type 2NephrologyHypertensionRegression AnalysisMicroalbuminuriaDrug Therapy CombinationbusinessDiabetic Angiopathiesmedicine.drugNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
researchProduct

Blood pressure control in treated hypertensive patients in daily practice of Latvian family physicians.

2011

Background and Objective. The aim of this study was to evaluate blood pressure (BP) control level in treated hypertensive patients in Latvia and to compare their characteristics according to the adequacy of BP control. Materials and Methods. Family physicians collected information on demographic and clinical characteristics, and current antihypertensive treatment of 455 18–80-year-old patients with essential arterial hypertension treated for 1 or more years. Target BP was defined as values of &lt;140/90 mm Hg for patients with low or moderate cardiovascular risk and &lt;135/85–125/75 mm Hg for patients with high or very high risk. BP was measured in the office setting after a 5-minute rest …

Blood pressure controlAdultMalemedicine.medical_specialtyAdolescentBlood Pressurearterial hypertension; blood pressure control; antihypertensive drugsSittingYoung AdultRisk groupsInternal medicineDaily practicemedicineAneroid sphygmomanometerHumansIn patientAntihypertensive AgentsAgedAged 80 and overControl levelbusiness.industryPhysicians FamilyBlood Pressure DeterminationGeneral MedicineMiddle AgedLatviaBlood pressureTreatment OutcomeHypertensionPhysical therapyFemalebusinessMedicina (Kaunas, Lithuania)
researchProduct

Home blood pressure control is low during the critical morning hours in patients with hypertension: the SURGE observational study

2011

Background. The morning blood pressure (BP) surge is associated with a peak increase in vascular events. Objective. The aim of this observational study was to evaluate morning BP control in treated hypertensive patients using home BP (HBP) monitoring and to compare these findings with clinic BP control. Methods. Clinic BP was measured twice during a 2-week period, prior to medication. Seated HBP was measured, using a BHS-validated device, three times per day over a 2-week period. Assessments included morning (06:00–11:59), lunchtime (12:00–14:00) and evening (18:00–22:00) HBP control (all <135/85 mmHg) and clinic BP (<140/90 mmHg) control. Results. A total of 15 618 patients were assessed. …

Blood pressure controlAdultMalemedicine.medical_specialtyEveningTime FactorsAdolescentPopulationYoung AdultMedicineHumansIn patientHome blood pressure monitoring hypertension morning blood pressure control.educationAntihypertensive AgentsMorningAgedAged 80 and overeducation.field_of_studybusiness.industryBlood Pressure DeterminationMED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREBlood Pressure Monitoring AmbulatoryMiddle AgedSurgeryCircadian RhythmBlood pressureTreatment OutcomeAnesthesiaHypertensionObservational studyFemaleDrug MonitoringFamily Practicebusiness
researchProduct

Effectiveness of an Interventional Program to Improve Blood Pressure Control in Hypertensive Patients at High Risk for Developing Heart Failure: HERO…

2010

J Clin Hypertens (Greenwich). The Efectividad de un Programa de Intervencion en el Control de la Presion Arterial de los Hipertensos en Riesgo de Desarrollar Insuficiencia Cardiaca (HEROIC) study was designed to assess whether an educational program for primary care physicians could improve blood pressure (BP) control in hypertensive patients at high risk for developing heart failure. The program contained a combination of educational training (live group sessions or online training) and information feedback. Two hundred twenty-six physicians completed the program and provided valid data in 2489 patients before and 2168 after 1 year. There was a small but significant reduction of −1.1 mm Hg…

Blood pressure controlMaleRiskmedicine.medical_specialtyEndocrinology Diabetes and MetabolismDeveloping heartBlood PressurePrimary carePhysiciansInternal MedicineMedicineHumansProspective StudiesPractice Patterns Physicians'Intensive care medicineAntihypertensive AgentsAgedHeart FailurePrimary Health Carebusiness.industrymedicine.diseaseOriginal PapersBlood pressureCross-Sectional StudiesTreatment OutcomeSpainHeart failureEmergency medicineHypertensionPractice Guidelines as TopicEducation Medical ContinuingFemaleCardiology and Cardiovascular MedicinebusinessInformation feedbackEducational programEducational trainingJournal of clinical hypertension (Greenwich, Conn.)
researchProduct